Glen Nowak

Dr. Glen Nowak

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Vaccine
Verified
Journal Article
Closed access
GNGlen Nowak
Glen Nowak
KSKristine Sheedy
Kristine Sheedy
KBKelli Bursey
Kelli Bursey
TSTeresa M. Smith
Teresa M. Smith
MBMichelle Basket
Michelle Basket

1 August 2015 in Vaccine
Verified
Journal Article
Open access
GNGlen Nowak
Glen Nowak
BGBruce G. Gellin
Bruce G. Gellin
NMNoni E. MacDonald
Noni E. MacDonald
RBRobb Butler
Robb Butler
Many countries and communities are dealing with groups and growing numbers of individuals who are delaying or refusing recommended vaccinations for themselves or their children. This has created a need for immunization programs to find approaches and strategies to address vaccine hesitancy. An important source of useful approaches and strategies is found in the frameworks, practices, and principles used by commercial and social marketers, many of which have been used by immunization programs. This review examines how social and commercial marketing principles and practices can be used to help address vaccine hesitancy. It provides an introduction to key marketing and social marketing concepts, identifies some of the major challenges to applying commercial and social marketing approaches to immunization programs, illustrates how immunization advocates and programs can use marketing and social marketing approaches to address vaccine hesitancy, and identifies some of the lessons that commercial and non-immunization sectors have learned that may have relevance for immunization. While the use of commercial and social marketing practices and principles does not guarantee success, the evidence, lessons learned, and applications to date indicate that they have considerable value in fostering vaccine acceptance.

3 December 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
BBBarry R. Bloom
Barry R. Bloom
GNGlen Nowak
Glen Nowak
WOWalter Orenstein
Walter Orenstein
In recent months, epidemiologists in the United States and throughout the world have been asked the same question by clinicians, journalists, and members of the public, “When will we have a vaccine?” The obvious answer to this question would be, “When a candidate vaccine is demonstrated to be safe, effective, and available. That can be determined only by scientific data, not by a target calendar date.” But we realize that such a response, although accurate, overlooks much of what people are ultimately seeking to understand.

1 May 2018 in American Journal of Infection Control
Verified
Journal Article
Closed access
SVSantosh Vijaykumar
Santosh Vijaykumar
GNGlen Nowak
Glen Nowak
IHItai Himelboim
Itai Himelboim
YJYan Jin
Yan Jin

1 January 2020 in Vaccine
Verified
Journal Article
Closed access
GNGlen Nowak
Glen Nowak
NENathaniel J. Evans
Nathaniel J. Evans
BWBartosz W. Wojdynski
Bartosz W. Wojdynski
SASun Joo (Grace) Ahn
Sun Joo (Grace) Ahn
MLMaria E. Len-Rios
Maria E. Len-Rios
DMDeborah McFalls
Deborah McFalls

1 March 2019 in Public Relations Review
Verified
Journal Article
Closed access
YJYan Jin
Yan Jin
LALucinda Austin
Lucinda Austin
SVSantosh Vijaykumar
Santosh Vijaykumar
HJHyoyeun Jun
Hyoyeun Jun
GNGlen Nowak
Glen Nowak